Target intelligence / Profile preview

Tear film and ocular surface

Molecular classification
Other (anatomical system, not a single molecule or molecular family)
01

Overview

The **tear film and ocular surface** are a tightly integrated anatomical and functional unit critical for vision, comfort, and protection of the eye. The tear film is comprised of three layers—lipid (outer), aqueous (middle), and mucin (inner)—spanning the corneal and conjunctival epithelium, and maintained through secretions of the lacrimal and meibomian glands. This multilayered structure provides lubrication, stability for optical refraction, defense against pathogens, and nourishment to ocular tissues. Dysfunction of any component can lead to **dry eye disease**, impaired vision, increased infection risk, and ocular discomfort. Therapeutic approaches focus on supplementing or restoring tear film integrity and treating underlying glandular or surface pathology, rather than targeting a specific molecule or receptor[1][3][5].

Other names
Ocular tear filmPre-corneal tear filmOcular surface
02

Mechanism of action

Drug supplementation of tear constituents (lubrication, hydration)[1][5] Anti-inflammatory modalities suppressing ocular surface immune activation[1] Stimulation of normal tear secretion and Meibomian gland function[1][5] Direct antimicrobial action (for infection)[5]

03

Biological functions

Lubrication of the ocular surface[1][6]Protection against environmental insults and pathogens[1][4][5]Maintenance of a smooth optical surface for vision/refractive clarity[2][3][5]Nourishment of corneal and conjunctival epithelium[1][3][4]Participation in immune and antimicrobial defense (via actual molecules present within the tear film)[1][4][5]
04

Disease associations

Dry eye disease[1][3][5]Ocular surface inflammation[1][5]Increased susceptibility to infection (when dysfunctional)[5]Neuropathic pain secondary to surface denervation or disease[1]
05

Safety considerations

Allergic or toxic response to topical agentsExacerbation of dry eye or destabilization of tear film with preservatives in drops[5]Infection risk if antimicrobial defenses are compromised[4][5]Long-term use of topical steroids: risk of elevated IOP, cataract, infection
06

Interacting drugs

Artificial tears (tear film supplementation/replacement)

4 more in the full profile.

07

Biomarkers

Tear break-up time (TBUT)[3]Tear volume/meniscus measurements (OCT imaging)[3]Concentrations of specific tear proteins (e.g. lysozyme, lactoferrin, sIgA)[4][5]Signs of surface damage (fluorescein staining, lid wiper epitheliopathy)[1][5]

Beyond the preview

Go deeper on Tear film and ocular surface.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tear film and ocular surface.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call